DiaMedica Therapeutics to Present Research at International Stroke Virtual Conference

Rhea-AI Summary

DiaMedica Therapeutics (Nasdaq: DMAC) has announced its participation in the American Heart Association 2021 International Stroke Conference. During the event, taking place from March 17-19, 2021, the company will present a plenary talk on the safety and tolerability of its recombinant human tissue kallikrein (DM199) for treating acute ischemic stroke, based on a randomized clinical trial. This conference is a leading global event focused on cerebrovascular disease. For more details, visit the conference's website.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical stage biopharmaceutical company developing novel recombinant proteins in the treatments for neurological and kidney diseases, today announced it will be presenting a plenary talk at the American Heart Association 2021 International Stroke Conference titled “Safety and Tolerability of Recombinant Human Tissue Kallikrein (DM199) In Acute Ischemic Stroke: A Randomized Clinical Trial”.

The International Stroke Conference is the world’s premier meeting dedicated to advancing the science and treatment of cerebrovascular disease. The virtual event will be held March 17-19, 2021. For additional information visit: https://professional.heart.org/es/meetings/international-stroke-conference.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) is a clinical stage biopharmaceutical company focused on developing novel treatments to improve the lives of patients with neurological and chronic kidney diseases. To learn more about DiaMedica, please visit www.diamedica.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210310005125/en/

FAQ

What will DiaMedica present at the American Heart Association 2021 International Stroke Conference?

DiaMedica will present a plenary talk on the safety and tolerability of its recombinant human tissue kallikrein (DM199) for acute ischemic stroke.

When is the American Heart Association 2021 International Stroke Conference?

The conference will take place from March 17-19, 2021.

Where can I find more information about the International Stroke Conference?

More information can be found on the conference's website at https://professional.heart.org/es/meetings/international-stroke-conference.

What company is presenting at the International Stroke Conference?

DiaMedica Therapeutics is the company presenting at the conference.

What is the stock symbol for DiaMedica Therapeutics?

The stock symbol for DiaMedica Therapeutics is DMAC.